Related Experiment Videos
The safety of remifentanil by bolus injection
Scott P Richardson1, Talmage D Egan
1Department of Anesthesiology, University of Utah, 3C 444 SOM, 30 N. 1900 E., Salt Lake City, Utah 84132-2304, USA. scott.richardson@hsc.utah.edu
Abstract:
Remifentanil is the newest of the fentanyl family of short-acting phenylpiperidine derivatives to be released into clinical practice. Remifentanil is a pure agonist at the mu opioid receptor with relatively little binding at the kappa, sigma or delta receptors. This is precisely the same profile as the other opioids currently popular in anaesthetic practice (fentanyl, alfentanil, sufentanil) and it offers the same advantages (profound analgesia, sedation, attenuation of the stress response). This has led to widespread use of remifentanil as an adjunct to general anaesthesia in a variety of clinical settings. The unique pharmacology of remifentanil, in particular its rapid offset, has more recently attracted clinicians and investigators to the use of remifentanil by bolus injection, especially for procedures requiring a brief, intense, opioid effect. The clinical effects of remifentanil, both therapeutic and adverse, are consistent with that of the other fentanyl congeners. However, the pharmacokinetic profile of remifentanil, that is, its rapid effect site equilibration, has also revealed a significant potential for therapeutic misadventure. The untoward effects of remifentanil, given by continuous infusion, are well-described in the literature. They are predictable and easily managed by experienced clinicians. This review will concentrate on the adverse effects of remifentanil given by bolus injection, either alone or in the context of a background infusion.
Insights
Remifentanil, a short-acting opioid, offers profound analgesia but its rapid offset requires careful administration. This review focuses on managing adverse effects of remifentanil when given by bolus injection.
Area of Science:
- Anesthesiology
- Pharmacology
- Clinical Practice
Background:
- Remifentanil is a short-acting phenylpiperidine derivative opioid.
- It acts as a pure agonist at mu-opioid receptors, similar to fentanyl, alfentanil, and sufentanil.
- Its unique rapid offset pharmacology has led to its use in brief, intense opioid effect procedures.
Purpose of the Study:
- To review the adverse effects of remifentanil when administered by bolus injection.
- To highlight potential therapeutic misadventures associated with remifentanil's pharmacokinetic profile.
- To differentiate management strategies for bolus versus continuous infusion administration.
Main Methods:
- Literature review focusing on adverse events of remifentanil.
- Analysis of pharmacokinetic and pharmacodynamic properties.
- Comparison of adverse effects from bolus injection versus continuous infusion.
Main Results:
- Clinical effects and adverse events are consistent with other fentanyl congeners.
- Rapid effect site equilibration presents a risk for therapeutic misadventure.
- Adverse effects from continuous infusion are well-documented and manageable.
Conclusions:
- Remifentanil's unique pharmacokinetic profile necessitates careful consideration of administration methods.
- Adverse effects from bolus injection require specific attention and management strategies.
- Understanding these effects is crucial for safe clinical application.
Related Concept Videos
Parenteral Anesthetics: Overview
Drug Delivery: Enteral Route
Drugs in...
Prevention of Further Absorption of Poison
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...